[Mucinous adenocarcinoma of the urachus].
OBJECTIVE
The Adenocarcinoma of the Urachus is very rare tumor, with an incidence of 1/5,000,000 inhabitants, represents less than 0.001 of all types of bladder cancer.


METHODS
A 51 year old man with a chronic history of suprapubic pain and hematuria. Physical examination and excretory urography were normal. The cystoscopy demonstrated a oedematosa area in cupola of bladder wall. The transuretral biopsy was moderately differentiated adenocarcinoma, with positive antibody to CK7 and CK20, the carcinoembryonic antigen was 6.6 ng/ml. Extended partial cystectomy was done, followed for chemotherapy and radiotherapy.


CONCLUSIONS
The treatment of adenocarcinoma of the urachus with a combination of extended partial cystectomy, chemotherapy and radiation, is a effective treatment.
Ojea Calvo
A
A
Servicio de Urología, Complejo Hospitalario Xeral-Cíes, Vigo, Pontevedra.
Núñez López
A
A
Domínguez Freire
F
F
Alonso Rodrigo
A
A
Rodríguez Iglesias
B
B
Benavente Delgado
J
J
Barros Rodríguez
J M
JM
González Piñeiro
A
A
Otero García
M
M
López Bellido
D
D
D002288:Adenocarcinoma, Mucinous / Q000737:chemistry / Q000473:pathology* / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D017024:Chemotherapy, Adjuvant; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D015653:Cystectomy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D007381:Intermediate Filament Proteins / Q000032:analysis; D053554:Keratin-20; D053552:Keratin-7; D007633:Keratins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000032:analysis; D018714:Radiotherapy, Adjuvant; D014497:Urachus / Q000473:pathology*; D001749:Urinary Bladder Neoplasms / Q000737:chemistry / Q000473:pathology* / Q000628:therapy; D000093542:Gemcitabine
D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D007381:Intermediate Filament Proteins; C507499:KRT20 protein, human; C507497:KRT7 protein, human; D053554:Keratin-20; D053552:Keratin-7; D009363:Neoplasm Proteins; D003841:Deoxycytidine; D007633:Keratins; D002945:Cisplatin; D000093542:Gemcitabine